Search company, investor...

Founded Year

2020

Stage

Unattributed - II | Alive

Total Raised

$520K

Last Raised

$480K | 2 yrs ago

About PsiloTec

PsiloTec is an integrated psychedelic drug development company.

Headquarters Location

855-2nd Street S.W. Suite 3500

Calgary, Alberta, T2P 4J8,

Canada

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Expert Collections containing PsiloTec

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PsiloTec is included in 1 Expert Collection, including Psychedelics.

P

Psychedelics

329 items

Latest PsiloTec News

Michichi Capital Corp. Terminates Qualifying Transaction with Zylorion Health Inc

Jan 13, 2023

Calgary, Alberta--(Newsfile Corp. - January 13, 2023) - Michichi Capital Corp. (TSXV: MCCP.P) ("Michichi"), a "Capital Pool Company" under TSX Venture Exchange (the "TSXV") Policy 2.4 (the "CPC Policy") announces that its previously announced "Qualifying Transaction", as such term is defined in the CPC Policy, will not be proceeding. On August 13, 2021, Michichi announced that it had entered into a non-binding letter of intent dated August 12, 2021 (the "LOI") with Zylorion Health Inc. ("Zylorion"), formerly known as PsiloTec Health Solutions Inc., pursuant to which Michichi and Zylorion intended to complete a business combination or other similarly structured transaction (the "Proposed Transaction") which would constitute an arm's length "Qualifying Transaction" for Michichi. Michichi and Zylorion have determined that they no longer wish to proceed with the Proposed Transaction and the previously announced LOI terminated in accordance with its terms. The common shares of Michichi are currently halted from trading on the TSXV but are expected to resume trading on the TSXV shortly. Michichi shall continue to identify and evaluate assets and businesses with a view to completing a Qualifying Transaction under the CPC Policy of the TSXV. About Michichi Capital Corp. Michichi was incorporated under the Business Corporations Act (British Columbia) on March 16, 2021 and its head office is located in Calgary, Alberta and its registered office is located in Vancouver, British Columbia. The common shares of Michichi ("Michichi Shares") are listed for trading on the TSXV under the stock symbol MCCP.P and Michichi is a reporting issuer in Alberta, British Columbia, Saskatchewan, Manitoba and Ontario. For further information contact: Cautionary Note Regarding Forward-Looking Statements Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or the Corporation's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, the evaluation of assets and businesses and the Corporation's expectation as to the resumption of trading of its common shares on the TSXV constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statement made in this press release are made as of the date hereof. The Corporation disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws. NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Not for distribution to United States newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities laws. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/151272 Sign up for Alerts Sign up to receive news releases by email for Michichi Capital Corp. or all companies belonging to the Banking/Financial Services industry.

PsiloTec Frequently Asked Questions (FAQ)

  • When was PsiloTec founded?

    PsiloTec was founded in 2020.

  • Where is PsiloTec's headquarters?

    PsiloTec's headquarters is located at 855-2nd Street S.W., Calgary.

  • What is PsiloTec's latest funding round?

    PsiloTec's latest funding round is Unattributed - II.

  • How much did PsiloTec raise?

    PsiloTec raised a total of $520K.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.